ResearcherUniversity of California San DiegoActive in the last 2 years

Dallas Gallagher

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5159141349. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

Pancreatic Enzyme Replacement Therapy (PERT) in Pancreatic Cancer: First U.S. Consensus Highlights on Dosing, Management, and Provider Inertia. Co-author DOI 10.1093/oncolo/oyag389 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Rebecca Munoz · 1 shared paper, 2026 · strength 0.26
- Paper Pancreatic Enzyme Replacement Therapy (PERT) in Pancreatic Cancer: First U.S. Consensus Highlights on Dosing, Managemen… DOI 10.1093/oncolo/oyag389 ↗
Maria Q. B. Petzel · 1 shared paper, 2026 · strength 0.26
- Paper Pancreatic Enzyme Replacement Therapy (PERT) in Pancreatic Cancer: First U.S. Consensus Highlights on Dosing, Managemen… DOI 10.1093/oncolo/oyag389 ↗
Amy Hacker‐Prietz · 1 shared paper, 2026 · strength 0.26
- Paper Pancreatic Enzyme Replacement Therapy (PERT) in Pancreatic Cancer: First U.S. Consensus Highlights on Dosing, Managemen… DOI 10.1093/oncolo/oyag389 ↗
Allison Rosenzweig · 1 shared paper, 2026 · strength 0.26
- Paper Pancreatic Enzyme Replacement Therapy (PERT) in Pancreatic Cancer: First U.S. Consensus Highlights on Dosing, Managemen… DOI 10.1093/oncolo/oyag389 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.